YERXA BENJAMIN R 4
4 · INSPIRE PHARMACEUTICALS INC · Filed May 5, 2010
Insider Transaction Report
Form 4
YERXA BENJAMIN R
EVP & Chf, Research & Develop
Transactions
- Sale
Common Stock
2010-05-03$6.78/sh−161$1,092→ 53,857 total - Sale
Common Stock
2010-05-03$6.70/sh−571$3,826→ 52,686 total - Sale
Common Stock
2010-05-03$6.79/sh−39$265→ 54,018 total - Sale
Common Stock
2010-05-03$6.82/sh−100$682→ 54,157 total - Sale
Common Stock
2010-05-03$6.69/sh−429$2,870→ 52,257 total - Sale
Common Stock
2010-05-03$6.77/sh−300$2,031→ 53,557 total - Sale
Common Stock
2010-05-03$6.75/sh−200$1,350→ 53,257 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Sales Plan Agreement adopted by the Reporting Person on June 3, 2009.